160 related articles for article (PubMed ID: 37854213)
21. Joint effect of THBS2 and VCAN accelerating the poor prognosis of gastric cancer.
Wang L; Feng L; Liu L; Han J; Zhang X; Li D; Liu J; Wang Y; Zuo J; Fan Z
Aging (Albany NY); 2023 Feb; 15(5):1343-1357. PubMed ID: 36842141
[TBL] [Abstract][Full Text] [Related]
22. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
23. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
[TBL] [Abstract][Full Text] [Related]
24. Differentially expressed genes
Jiang K; Liu H; Xie D; Xiao Q
Oncol Lett; 2019 Mar; 17(3):3191-3202. PubMed ID: 30867749
[TBL] [Abstract][Full Text] [Related]
25. Pan-Cancer Analysis of the Oncogenic and Immunological Role of
Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K
Front Oncol; 2022; 12():811567. PubMed ID: 35651805
[TBL] [Abstract][Full Text] [Related]
26. Versican core protein aids in the diagnosis and grading of breast phyllodes tumor.
Zhang L; Bi J; Yu X; Li X; Liu X; Weng X; Shao M
Ann Diagn Pathol; 2023 Oct; 66():152176. PubMed ID: 37423116
[TBL] [Abstract][Full Text] [Related]
27. A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.
Yu C; You M; Zhang P; Zhang S; Yin Y; Zhang X
Cancer Med; 2021 Jul; 10(13):4629-4643. PubMed ID: 34121340
[TBL] [Abstract][Full Text] [Related]
28. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis reveals
Zhu Z; Xu J; Li L; Ye W; Chen B; Zeng J; Huang Z
Transl Cancer Res; 2020 Jul; 9(7):4093-4110. PubMed ID: 35117779
[TBL] [Abstract][Full Text] [Related]
30. Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma.
Huang WT; Liu AG; Cai KT; He RQ; Li Z; Wei QJ; Chen MY; Huang JY; Yan WY; Zhou H; Chen G; Ma J
Am J Transl Res; 2019; 11(12):7538-7554. PubMed ID: 31934299
[TBL] [Abstract][Full Text] [Related]
31. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
Lin Y; Dong Y; Liu W; Fan X; Sun Y
Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
[TBL] [Abstract][Full Text] [Related]
32. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
33. RelB is a potential molecular biomarker for immunotherapy in human pan-cancer.
Wu J; Yu X; Zhu H; Chen P; Liu T; Yin R; Qiang Y; Xu L
Front Mol Biosci; 2023; 10():1178446. PubMed ID: 37388242
[No Abstract] [Full Text] [Related]
34. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():927988. PubMed ID: 35756681
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
36. Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity.
Li L; Huang Z; Du K; Liu X; Li C; Wang D; Zhang Y; Wang C; Li J
Front Pharmacol; 2022; 13():900699. PubMed ID: 35668930
[No Abstract] [Full Text] [Related]
37. Pan-cancer analysis of the prognostic and immunological roles of
Liu S; Liu Y; Zhang X; Song X; Zhang B; Zhang Y
Front Genet; 2022; 13():1039440. PubMed ID: 36313454
[No Abstract] [Full Text] [Related]
38. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
Huang W; Xiao Y; Wang H; Chen G; Li K
Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
[TBL] [Abstract][Full Text] [Related]
39. A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.
Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
Front Public Health; 2022; 10():969070. PubMed ID: 36051999
[TBL] [Abstract][Full Text] [Related]
40. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression.
Wang Z; Zeng Z; Gao F; Gui Z; Du J; Shen N; Shang Y; Yang Z; Shang L; Wei R; Ma W; Wang C
BMC Med Genomics; 2023 Feb; 16(1):30. PubMed ID: 36803385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
